A new study adds to a growing body of evidence that Parkinson’sdisease, long believed to have its origins in the brain, may begin in the gut. Gastrointestinal problems are common in patients ...
We are excited to initiate this trial of VTX3232 in patients with early Parkinson’s disease,” said Mark Forman, MD, PhD, Chief Medical Officer. “There is a compelling body of evidence from the ...